Latest Leadership Changes News

Kip McGrath Education Centres Limited reported steady FY26 results with $30.1 million revenue and a 25% EBITDA margin despite a slight revenue dip. The company is navigating network consolidation and operational resets while facing a $0.73 per share takeover offer from Crimson.

TMK Energy has increased its average daily gas production by 5% in July 2026, with August figures already surpassing 800m3/day. The company is advancing its 2026 Work Program and finalising design for a Gas to Power Project, targeting first power generation by year-end.

IRIS Metals has appointed Simon Iacopetta as Strategic Advisor and promoted Chris Evans to Executive Chairman, signalling a sharpened focus on expanding its critical minerals portfolio in North America.

RPM Automotive's CEO Roy Norris resigned following mutual agreement with the board amid strategic leadership discussions. The company is launching a search for a new CEO and aims to bolster its governance with new independent directors.

Corporate Travel Management (ASX:CTD) has extended its exclusive contract with the UK Ministry of Defence to provide accommodation services for the Afghan Resettlement Programme, with expected transaction values reaching £28 million in the first six months.

Metallium Limited has appointed key board members and executives to strengthen governance and operational capacity as it advances its Flash Joule Heating technology towards commercialisation in the US.

Integral Diagnostics (ASX: IDX) posted strong preliminary FY26 results with revenue nearing $790 million and operating EBITDA up 30%, while announcing Jenny Martin as incoming CFO amid leadership transitions.

Percheron Therapeutics announces Dr Michael Baker as incoming CEO, replacing Dr James Garner who steps down after three years. Baker’s appointment aligns executive incentives with shareholder value as the company prepares for a pivotal HMBD-002 clinical trial.

Coppermoly Limited's Managing Director and CEO Dickson Leah has resigned for personal reasons but will oversee a handover as the board searches for a successor. The company continues to focus on its expanding copper, gold, and critical minerals portfolio across Queensland and Western Australia.

EVE Health Group has progressed its Libbo pilot clinical study for erectile dysfunction with dosing set for Q4 2026 and achieved a major solubility breakthrough for apixaban, while appointing Ben Rohr as CEO to drive commercial growth.

Integral Diagnostics has installed Jason Martinez as its new CEO, marking a leadership change as the company prepares to present its FY26 results. Martinez brings over 20 years of diagnostic imaging experience and aims to drive growth and innovation following the retirement of long-serving CEO Ian Kadish.

SciDev Ltd has landed its first contracts in the data centre sector, targeting water recycling and treatment services for two major Australian hyperscale operators. The deals are expected to generate around $0.5 million in revenue in the first half of FY27, marking a strategic step into a high-growth market.